 EXFORGE D
|
Siegfried
|
| valsartán+hidrocloroti.+amlodip. |
Antihipertensivo |
| 160/12.5/10 mg comp.x 28 | $54.653,72 | (22/08/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $27.326,86 |
|
|
|
|
| 160/12.5/5 mg comp.x 28 | $55.178,69 | (22/08/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $27.589,35 |
|
|
|
|
| 160/25/10 mg comp.x 28 | $55.178,69 | (22/08/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $27.589,35 |
|
|
|
|
| 160/25/5 mg comp.x 28 | $55.178,69 | (22/08/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $27.589,35 |
|
|
|
|
| 320/25/10 mg comp.x 28 | $58.354,56 | (22/08/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $29.177,28 |
|
|
|
|
| |
